0
Your cart

Your cart is empty

Books > Earth & environment > The environment > Pollution & threats to the environment

Buy Now

Guidance on PFAS Exposure, Testing, and Clinical Follow-Up (Paperback) Loot Price: R1,230
Discovery Miles 12 300
Guidance on PFAS Exposure, Testing, and Clinical Follow-Up (Paperback): National Academies of Sciences, Engineering, and...

Guidance on PFAS Exposure, Testing, and Clinical Follow-Up (Paperback)

National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Division on Earth and Life Studies, Board on Population Health and Public Health Practice, Board on Environmental Studies and Toxicology, Committee on the Guidance on PFAS Testing and Health Outcomes

 (sign in to rate)
Loot Price R1,230 Discovery Miles 12 300 | Repayment Terms: R115 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

In thousands of communities across the United States, drinking water is contaminated with chemicals known as perfluoroalkyl and polyfluoroalkyl substances (PFAS). PFAS are used in a wide range of products, such as non-stick cookware, water and stain repellent fabrics, and fire-fighting foam, because they have properties that repel oil and water, reduce friction, and resist temperature changes. PFAS can leak into the environment where they are made, used, disposed of, or spilled. PFAS exposure has been linked to a number of adverse health effects including certain cancers, thyroid dysfunction, changes in cholesterol, and small reductions in birth weight. This report recommends that the Centers for Disease Control and Prevention (CDC) update its clinical guidance to advise clinicians to offer PFAS blood testing to patients who are likely to have a history of elevated exposure, such as those with occupational exposures or those who live in areas known to be contaminated. If testing reveals PFAS levels associated with an increased risk of adverse effects, patients should receive regular screenings and monitoring for these and other health impacts. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up recommends that the CDC, Agency for Toxic Substances and Disease Registry (ATSDR), and public health departments support clinicians by creating educational materials on PFAS exposure, potential health effects, the limitations of testing, and the benefits and harms of testing. Table of Contents Front Matter Summary 1 Introduction 2 Principles for Decision Making Under Uncertainty 3 Potential Health Effects of PFAS 4 PFAS Exposure Reduction 5 PFAS Testing and Concentrations to Inform Clinical Care of Exposed Patients 6 Guidance for Clinicians on Exposure Determination, PFAS Testing, and Clinical Follow-Up 7 Revising ATSDR's PFAS Clinical Guidance 8 Implementing the Committee's Recommendations to Improve Public Health Appendix A: Committee Member, Staff, and Community Liaison Biographies Appendix B: Summary of the Committee's Town Halls Appendix C: Public Meeting Agendas Appendix D: Evidence Review: Methods and Approach Appendix E: White Paper: Review of the PFAS Personal Intervention Literature

General

Imprint: National Academies Press
Country of origin: United States
Release date: September 2022
Authors: National Academies of Sciences, Engineering, and Medicine • Health and Medicine Division • Division on Earth and Life Studies • Board on Population Health and Public Health Practice • Board on Environmental Studies and Toxicology • Committee on the Guidance on PFAS Testing and Health Outcomes
Dimensions: 279 x 216mm (L x W)
Format: Paperback
Pages: 300
ISBN-13: 978-0-309-48244-8
Categories: Books > Medicine > General
Books > Earth & environment > The environment > Pollution & threats to the environment > General
LSN: 0-309-48244-5
Barcode: 9780309482448

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners